Showing results (371-380 of 445) with videos related to
Sort By:
Pageof 45
Clinical Epigenetics|February 11, 2017
Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survivalJohn K Wiencke, Devin C Koestler, Lucas A Salas, et al.Journal of Neuro-Oncology|September 15, 2016
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningiomaSeunggu J Han, Gerald Reis, Gary Kohanbash, et al.Clinical Epigenetics|October 29, 2022
Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarkerEmily Tang, John K Wiencke, Gayathri Warrier, et al.Neuro-Oncology|October 15, 2021
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imagingJulia Cluceru, Yannet Interian, Joanna J Phillips, et al.Cancer|August 1, 2017
Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomasMichael Wahl, Susan M Chang, Joanna J Phillips, et al.Neuro-Oncology|August 20, 2016
Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivorsErika Roddy, Katherine Sear, Erin Felton, et al.NPJ Precision Oncology|November 18, 2024
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapyZe Zhang, Kartik Sehgal, Keisuke Shirai, et al.Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.Neuro-Oncology Practice|September 27, 2019
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survivalChristopher H Chapman, Jared H Hara, Annette M Molinaro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.Pageof 45